HomeSKYE • NASDAQ
add
Skye Bioscience Inc
Previous close
$3.96
Day range
$4.05 - $4.05
Year range
$1.44 - $19.41
Market cap
120.14M USD
Avg Volume
409.56K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
CNBC
14 minutes ago
10 things to watch in the stock market Friday including a bullish call on
Best Buy
0.00%
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.41M | 195.67% |
Net income | -7.90M | -153.99% |
Net profit margin | — | — |
Earnings per share | -0.20 | — |
EBITDA | -8.38M | -198.18% |
Effective tax rate | -0.10% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 74.12M | 8,762.39% |
Total assets | 87.26M | 3,802.67% |
Total liabilities | 14.45M | 44.16% |
Total equity | 72.81M | — |
Shares outstanding | 30.34M | — |
Price to book | 1.53 | — |
Return on assets | -23.08% | — |
Return on capital | -26.01% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -7.90M | -153.99% |
Cash from operations | -7.09M | -256.13% |
Cash from investing | -32.46K | — |
Cash from financing | -2.10M | -1,598.41% |
Net change in cash | -9.22M | -335.98% |
Free cash flow | -6.97M | -792.99% |
About
Founded
2011
Website
Employees
11
